No Data
No Data
No Data
FanPep, Kids Bio, and others.
The forecast for this period's operating profit has been revised down to 0.39 billion yen from 1.619 billion yen.
Shimamura, operating profit in 25/2 increased by 7.1% to 59.2 billion yen, Financial Estimates for 26/2 increased by 2.4% to 60.6 billion yen.
The performance for the fiscal year ending February 2025 announced by Shimamura <8227> shows that revenue increased by 4.8% compared to the previous period, reaching 665.3 billion 58 million yen, and operating profit increased by 7.1%, amounting to 59.2 billion 40 million yen. In the Shimamura business, with the main private brand "CLOSSHI," products that solve customer anxieties and dissatisfaction, such as the long-lasting series "Hebirote" and the sleep space Resistance series "Minmin Lab," were sold, while enhancing the added value of the high-priced PB.
Tential: Notice regarding revisions to full-year earnings forecasts due to changes in fiscal period
Tenshial has risen for three consecutive days, viewed as a factor for the continuous update of record profits.
Recovery wear giant TENTIAL (Tensharu) <325A.T> has seen three consecutive rises. At one point, it reached 2,996 yen, up 277 yen from the previous day. After the close on the 17th, it announced the standalone financial results for the January 2025 period and the performance estimates for the January 2026 period, which were perceived as positive for buying. The operating profit for the January 2025 period rose to 1.452 billion yen (3.1 times compared to the previous term), setting a new record. The operating profit estimate for the January 2026 period is 1.619 billion yen (an increase of 11.5%). The Commodity ETF lineup and customer interfaces are being expanded.
TENTIAL---significantly extended, announced performance for the period ending January 2025.
Significant gains for three consecutive days. Announced performance for the January 2025 period, achieving substantial revenue of 12.837 billion yen (+237.3% year-on-year), gross profit of 9.237 billion yen (+244.3% year-on-year), and operating profit of 1.452 billion yen (+306.9%). The financial estimates for the January 2026 period also indicate that, due to the expansion of business scale, revenue is expected to be 16.973 billion yen (+132.2% compared to the previous period), gross profit is projected to be 12.363 billion yen (+133.8% compared to the previous period), and operating profit is anticipated to be 1.619 billion yen.
Tanaka Chemical Research, revised deficit for 25/3 operating loss of -0.45 billion yen from -0.9 billion yen.
Tanaka Chemical Research Co., Ltd. <4080> announced a revision of its financial estimates for the fiscal year ending March 2025. Revenue has been revised down from 38 billion yen to 36 billion yen, and operating loss has been lowered from a loss of 0.9 billion yen to a loss of 0.45 billion yen. The slowdown in the growth of the EV market has significantly impacted this, with sales volumes decreasing more than expected. On the profit side, inventory valuation losses of 1.398 billion yen were recorded. 【Positive Evaluation】 <5136> tripla Four | <325A> TENTIAL Annual <3169> Misawa Annual | <3467> Agree City D Revision <